NASDAQ: BEAMBeam Therapeutics Inc Stock Ownership - Who owns Beam Therapeutics?
Insider buying vs selling
Have Beam Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Fmr LLC | 10% Owner | 2025-10-27 | 459 | $26.68 | $12.25kSell |
| John M. Evans | CEO | 2025-10-02 | 25,000 | $24.63 | $615.68kSell |
| John M. Evans | CEO | 2025-10-02 | 25,000 | $0.67 | $16.75kBuy |
| John M. Evans | CEO | 2025-10-01 | 25,000 | $0.67 | $16.75kBuy |
| Christine Bellon | Chief Legal Officer | 2025-10-01 | 373 | $24.53 | $9.15kSell |
| Bethany J. Cavanagh | SVP Finance and Treasurer | 2025-10-01 | 467 | $24.53 | $11.46kSell |
| John M. Evans | CEO | 2025-10-01 | 25,000 | $24.51 | $612.65kSell |
| Fmr LLC | 10% Owner | 2025-07-30 | 48,374 | $20.50 | $991.67kSell |
| Amy Simon | Chief Medical Officer | 2025-07-03 | 876 | $20.12 | $17.63kSell |
| Amy Simon | Chief Medical Officer | 2025-07-01 | 374 | $16.94 | $6.34kSell |
BEAM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when BEAM insiders and whales buy or sell their stock.
BEAM Shareholders
What type of owners hold Beam Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Fmr LLC | 12.81% | 12,961,459 | $324.17M | Institution |
| Farallon Capital Management LLC | 9.90% | 10,013,111 | $250.43M | Institution |
| Vanguard Group Inc | 9.59% | 9,706,224 | $242.75M | Institution |
| Ark Investment Management LLC | 8.75% | 8,847,841 | $221.28M | Institution |
| Blackrock Inc | 7.91% | 8,002,689 | $200.15M | Institution |
| Fmr LLC | 4.70% | 4,752,601 | $118.86M | Insider |
| Sumitomo Mitsui Trust Group Inc | 4.68% | 4,729,444 | $118.28M | Institution |
| Nikko Asset Management Americas Inc | 4.67% | 4,726,799 | $118.22M | Institution |
| Arch Venture Management LLC | 4.49% | 4,540,132 | $113.55M | Institution |
| State Street Corp | 3.60% | 3,638,266 | $90.99M | Institution |
BEAM vs Biotech Stocks
Beam Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.